Targeting microbial metabolites to treat autism
- PMID: 35165452
- DOI: 10.1038/s41591-022-01711-8
Targeting microbial metabolites to treat autism
Comment on
-
A gut-derived metabolite alters brain activity and anxiety behaviour in mice.Nature. 2022 Feb;602(7898):647-653. doi: 10.1038/s41586-022-04396-8. Epub 2022 Feb 14. Nature. 2022. PMID: 35165440 Free PMC article.
-
Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial.Nat Med. 2022 Mar;28(3):528-534. doi: 10.1038/s41591-022-01683-9. Epub 2022 Feb 14. Nat Med. 2022. PMID: 35165451 Clinical Trial.
References
-
- Cryan, J. F. et al. Physiol. Rev. 99, 1877–2013 (2019). - DOI
-
- Campbell, A. S. et al. Nat. Med. https://doi.org/10.1038/s41591-022-01683-9 (2022). - DOI - PubMed
-
- Needham, B. D. et al. Nature https://doi.org/10.1038/s41586-022-04396-8 (2022). - DOI - PubMed
-
- Swann, J. R., Spitzer, S. O. & Diaz Heijtz, R. Metabolites 10, 172 (2020). - DOI
-
- Hsiao, E. Y. et al. Cell 155, 1451–1463 (2013). - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
